Streetbeat News

Products Services

HRB

H&R Block advises taxpayers to conduct tax assessments as IRS data shows higher average refunds but fewer recipients in 2024. The company is offering free mid-year care check-ins to ensure maximum refunds next tax season.

Portfolio Pulse from Benzinga Newsdesk

August 01, 2024 | 12:04 pm

OPTT

Ocean Power Technologies (NYSE:OPTT) has announced a patent pending for its new docking and recharging buoy technology designed for the Wave Adaptive Modular Vessel (WAM-V) Unmanned Surface Vehicle (USV). This innovation enhances the operational efficiency and range of USVs, making it valuable for oceanographic research, environmental monitoring, and defense applications.

Portfolio Pulse from Benzinga Newsdesk

August 01, 2024 | 12:04 pm

ENPH

VGK

Enphase Energy has started shipping its IQ8 Microinverters to support high-powered solar modules in several European countries including France, Germany, Spain, Bulgaria, Estonia, Slovakia, and Croatia.

Portfolio Pulse from Benzinga Newsdesk

August 01, 2024 | 12:03 pm

SLB

SLB and Aker Carbon Capture have been awarded a Front-End Engineering Design (FEED) contract by CO280 to remove 800,000 tonnes of carbon emissions at a pulp and paper mill on the U.S. Gulf Coast.

Portfolio Pulse from Benzinga Newsdesk

August 01, 2024 | 11:58 am

GOGO

Gogo Business Aviation is collaborating with Duncan Aviation to pursue a Supplemental Type Certificate (STC) from the FAA for the installation of Gogo 5G on Bombardier Learjet 40/45/70/75 aircraft.

Portfolio Pulse from Benzinga Newsdesk

August 01, 2024 | 11:54 am

ETHE

IBIT

Bitcoin experienced a 2.3% decline to $64,500 despite significant inflows into Bitcoin spot ETFs, particularly from BlackRock and Grayscale. Ethereum also saw a decline, with substantial outflows from its ETFs. The broader cryptocurrency market showed weakness, but long-term prospects remain optimistic.

Portfolio Pulse from Murtuza Merchant

August 01, 2024 | 11:52 am

PDSB

PDS Biotechnology Corporation (NASDAQ:PDSB) has aligned with the FDA on the next steps for its Phase 3 VERSATILE-003 trial targeting HPV16-positive head and neck cancer. The trial is set to begin in Q4 2024. A conference call will be held today at 8:00 a.m. ET to discuss the details.

Portfolio Pulse from Benzinga Newsdesk

August 01, 2024 | 11:51 am

TNXP

Tonix Pharmaceuticals (NASDAQ:TNXP) has received FDA Fast Track designation for its fibromyalgia treatment, TNX-102 SL. This designation facilitates the development and review process, potentially bringing the drug to market sooner. TNX-102 SL has shown significant improvements in fibromyalgia symptoms in Phase 3 trials and is well tolerated. Tonix plans to submit a New Drug Application (NDA) in the second half of the year and may request Priority Review.

Portfolio Pulse from Benzinga Newsdesk

August 01, 2024 | 11:49 am

BA

Boeing's defense, space, and security segment reported a $913 million loss in Q2, with overall revenues dipping 15% to $16.87 billion. The losses are attributed to delays in the Starliner spacecraft and other fixed-price programs. Boeing's stock closed up 2% at $190.6 but is down 24.3% year-to-date.

Portfolio Pulse from Anan Ashraf

August 01, 2024 | 11:49 am

ALXO

ALX Oncology Holdings shares are trading lower following the announcement of topline data from its ASPEN-06 Phase 2 trial.

Portfolio Pulse from Benzinga Newsdesk

August 01, 2024 | 11:49 am